Gastrin-Releasing Peptide Antibodies

Santa Cruz Biotechnology features a diverse variety of Gastrin-Releasing Peptide Antibodies for research focused on understanding gastrin-releasing peptide (GRP) in various biological processes. Gastrin-Releasing Peptide Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Gastrin-releasing peptide is a neuropeptide that plays a crucial role in stimulating gastric acid secretion and regulating gastrointestinal motility. GRP influences multiple physiological functions, including the modulation of anxiety and stress responses. Research has shown that gastrin-releasing peptide significantly impacts cellular signaling pathways and tissue development. Understanding GRP mechanisms can provide insights into gastrointestinal disorders and potential therapeutic targets. Ongoing studies continue to reveal new functions of gastrin-releasing peptide in health and disease. Current research highlights the importance of GRP in neural development and cancer biology. Santa Cruz Biotechnology monoclonal antibodies for gastrin-releasing peptide support researchers worldwide in advancing scientific understanding of this significant neuropeptide.